The privately held Pune-based company aims to first bring generic drugs to the market through the company’s own Ramp;D efforts and innovative molecules through licensingfrom Moneycontrol Business News https://ift.tt/3vCY6bh
Friday, June 18, 2021
Emcure says it will continue growth momentum in FY22 by deepening product portfolio, digital focus
The privately held Pune-based company aims to first bring generic drugs to the market through the company’s own Ramp;D efforts and innovative molecules through licensingfrom Moneycontrol Business News https://ift.tt/3vCY6bh
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment